Form 4 for MRNA Moderna
Accepted 2023-05-31 00:00:00 ET · period of report 2023-05-26 · accession 0001127602-23-017228 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-31 | 2023-05-26 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,410 | 1.63M | +0.1% | — |
| D | 2023-05-31 | 2023-05-30 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $124.95 | -1,181 | 1.63M | -0.1% | -$147.6K |
| D | 2023-05-31 | 2023-05-26 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -2,410 | 7,233 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-26 | M | A | 2,410 | — | 1,633,142 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-05-30 | S | D | 1,181 | $124.95 | 1,631,961 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-05-26 | M | D | 2,410 | $0.00 | 7,233 | D | — · — to — | 2,410 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F4) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |